Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 82
  • Journal CiteScore: 35.06
  • Journal Impact Factor: 24.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Megan T. Metamar

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, United States

Publications
  • Short Communication   
    Pancreatic Cancer Remains a Deadly Disease. Why?
    Author(s): Megan T. Metamar*

    In comparison to many other malignancies, pancreatic cancer has an extremely low cumulative five-year survival rate-the percentage of all patients who are alive for five years after diagnosis-of about 5 to 10%. This is because considerably more people are diagnosed with stage IV disease after it has spread. Pancreatic cancer is the most lethal of all common malignancies and delays in detection and treatment can be fatal. When pancreatic cancer is detected early enough, it is possible to remove the pancreas, which is the sole cure for the condition. Only 10% of people with pancreatic cancer are discovered in time for life-saving surgery. Although pancreatic cancer is uncommon, it is one of the worst types of cancer. This is because symptoms usually do not appear until the malignancy is advanced, making treatment difficult. .. View More»

    DOI: 10.35841/1590-8577- 23.11.777

    Abstract HTML PDF